Literature DB >> 12438437

IFN-gamma suspends the killing license of anti-tumor CTLs.

Aron E Lukacher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12438437      PMCID： PMC151825          DOI： 10.1172/JCI17209

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  21 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells.

Authors:  Christopher W McMahon; Allan J Zajac; Amanda M Jamieson; Laura Corral; Gianna E Hammer; Rafi Ahmed; David H Raulet
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

3.  Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.

Authors:  N Rouas-Freiss; R M Gonçalves; C Menier; J Dausset; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Authors:  V M Braud; D S Allan; C A O'Callaghan; K Söderström; A D'Andrea; G S Ogg; S Lazetic; N T Young; J I Bell; J H Phillips; L L Lanier; A J McMichael
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 5.  Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses.

Authors:  M C Mingari; A Moretta; L Moretta
Journal:  Immunol Today       Date:  1998-04

6.  Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.

Authors:  M Valés-Gómez; H T Reyburn; R A Erskine; M López-Botet; J L Strominger
Journal:  EMBO J       Date:  1999-08-02       Impact factor: 11.598

7.  IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.

Authors:  Karl-Johan Malmberg; Victor Levitsky; Håkan Norell; Cristina Teixeira de Matos; Mattias Carlsten; Kjell Schedvins; Hodjattallah Rabbani; Alessandro Moretta; Kalle Söderström; Jelena Levitskaya; Rolf Kiessling
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

8.  CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.

Authors:  Joseph D Miller; Michael Peters; Alp E Oran; Guy W Beresford; Laurie Harrington; Jeremy M Boss; John D Altman
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

9.  In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.

Authors:  D E Speiser; M J Pittet; D Valmori; R Dunbar; D Rimoldi; D Liénard; H R MacDonald; J C Cerottini; V Cerundolo; P Romero
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

10.  Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).

Authors:  R E Vance; J R Kraft; J D Altman; P E Jensen; D H Raulet
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307
View more
  4 in total

Review 1.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

2.  Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.

Authors:  Shawn S Jackson; Jörn E Schmitz; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

3.  CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy.

Authors:  Jian Li; Jin-Na Chen; Ting-Ting Zeng; Fan He; Shu-Peng Chen; Stephanie Ma; Jiong Bi; Xiao-Feng Zhu; Xin-Yuan Guan
Journal:  BMC Cancer       Date:  2016-01-13       Impact factor: 4.430

4.  Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors.

Authors:  Alexander I Autenshlyus; Sergey A Arkhipov; Tatiana A Kunts; Igor O Marinkin; Elena S Mikhailova; Xenia V Karpukhina; Nikolay A Varaksin
Journal:  Int J Immunopathol Pharmacol       Date:  2017-01-24       Impact factor: 3.219
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.